Efficacy of Vibrating Capsule in Patients With Chronic Constipation

NCT ID: NCT03508076

Last Updated: 2018-04-25

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

27 participants

Study Classification

INTERVENTIONAL

Study Start Date

2017-02-01

Study Completion Date

2018-06-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Constipated patients in the participating center from February 2017 to June 2018 (anticipated) were prospectively enrolled. Number of defecation per week,Bristol score,and Colon transmission experiment were compared with the constipated patients before treatment.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Constipation affects the quality of life of patients, some patients abuse laxatives or repeated medical treatment, increased medical costs. At present, the main treatment of constipation is to adjust life style, medicine, psychotherapy, biofeedback and surgical treatment. However, the above methods are associated with adverse reactions, and the patient's satisfaction is still low. A new approach is needed to solve this clinical problem.

Investigators have developed a vibration capsule that can be adjusted in different modes.

Preliminary animal experiments showed that the capsule was safe and increased the number of defecation.

This study is a clinical research for patients with constipation, to explore the effect in different vibrating modes in patients with constipation and tract emptying transmission and its effectiveness.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Chronic Constipation

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

DOUBLE

Participants Investigators

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Sham Capsule

Patients swallowed 1 sham Vibrating capsule with water every three days,recorded his defecation time, defecation frequency and bristol score.The total capsule need to take 12.

Group Type SHAM_COMPARATOR

Sham Capsule

Intervention Type DEVICE

Capsules can't vibrate but look the same as Vibrating Capsule

Vibration Capsule of low level

Patients swallowed 1 low level vibration Capsule Vibrating capsule with water every three days,recorded his defecation time, defecation frequency and bristol score.The total capsule need to take 12.

Group Type EXPERIMENTAL

Vibrating Capsule

Intervention Type DEVICE

Patients in this group would be treated with Vibrating Capsule

Vibration Capsule of high level

Patients swallowed 1 high level vibration Capsule Vibrating capsule with water every three days,recorded his defecation time, defecation frequency and bristol score.The total capsule need to take 12.

Group Type EXPERIMENTAL

Vibrating Capsule

Intervention Type DEVICE

Patients in this group would be treated with Vibrating Capsule

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Vibrating Capsule

Patients in this group would be treated with Vibrating Capsule

Intervention Type DEVICE

Sham Capsule

Capsules can't vibrate but look the same as Vibrating Capsule

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Adult patients aged form 18 to 80
* Clinical diagnosis of functional constipation
* Must be able to swallow vibrating capsule

Exclusion Criteria

* complex history of gastrointestinal diverticula, obstruction, ulcer, bleeding, stenosis or fistula.
* recent use of banned drugs.
* patients who are preparing for mri.
Minimum Eligible Age

18 Years

Maximum Eligible Age

80 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Changhai Hospital

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Zhuan Liao

Deputy Director

Responsibility Role PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Changhai Hospital

Shanghai, Shanghai Municipality, China

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

China

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Zhuan Liao, professor

Role: primary

13061921980

References

Explore related publications, articles, or registry entries linked to this study.

Yu J, Qian YY, He CH, Zhu SG, Zhao AJ, Zhu QQ, Shao CW, Wang TG, Wang Y, Ding GL, Liao Z, Li ZS. Safety and Efficacy of a New Smartphone-controlled Vibrating Capsule on Defecation in Beagles. Sci Rep. 2017 Jun 6;7(1):2841. doi: 10.1038/s41598-017-02844-4.

Reference Type RESULT
PMID: 28588191 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

Vibrating Capsule

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

CMTS4520 for Chronic Constipation in Adults
NCT06832137 NOT_YET_RECRUITING PHASE1/PHASE2